New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Study validates first-in-class AI-driven digital pathology colorectal cancer diagnostic tool

Study validates first-in-class AI-driven digital pathology colorectal cancer diagnostic tool

In a peer-reviewed study published today inNature Communications, a team of scientists from French-American techbio Owkin and pathology labs in France present a blind validation of MSIntuit™ CRC
World medicine November 15,2023
Study validates first-in-class AI-driven digital pathology colorectal cancer diagnostic tool

Study validates first-in-class AI-driven digital pathology colorectal cancer diagnostic tool

In a peer-reviewed study published today inNature Communications, a team of scientists from French-American techbio Owkin and pathology labs in France present a blind validation of MSIntuit™ CRC
World medicine November 15,2023
Targeting MYC-SPT5 interaction could lead to novel cancer therapies

Targeting MYC-SPT5 interaction could lead to novel cancer therapies

MYC family genes are essential for the human organism. According to current knowledge, they regulate the expression of most cellular genes. Misregulation of MYC proteins significantly contributes to t
World medicine November 15,2023
Targeting MYC-SPT5 interaction could lead to novel cancer therapies

Targeting MYC-SPT5 interaction could lead to novel cancer therapies

MYC family genes are essential for the human organism. According to current knowledge, they regulate the expression of most cellular genes. Misregulation of MYC proteins significantly contributes to t
World medicine November 15,2023
AI-powered radiation therapy revolutionizes cancer treatment at Henry Ford West Bloomfield Hospital

AI-powered radiation therapy revolutionizes cancer treatment at Henry Ford West Bloomfield Hospital

Patients undergoing radiation therapy for certain types of cancer at Henry Ford West Bloomfield Hospital are among the first in the country with access to a cutting-edge treatment system that increase
World medicine November 15,2023
AI-powered radiation therapy revolutionizes cancer treatment at Henry Ford West Bloomfield Hospital

AI-powered radiation therapy revolutionizes cancer treatment at Henry Ford West Bloomfield Hospital

Patients undergoing radiation therapy for certain types of cancer at Henry Ford West Bloomfield Hospital are among the first in the country with access to a cutting-edge treatment system that increase
World medicine November 15,2023
Gamma delta T cells engineered to be more potent and long-lasting against cancer

Gamma delta T cells engineered to be more potent and long-lasting against cancer

UCLA scientists have developed a new method to engineer more powerful immune cells that can potentially be used for "off-the-shelf" cell therapy to treat challenging cancers."Off-the-sh
World medicine November 15,2023
Gamma delta T cells engineered to be more potent and long-lasting against cancer

Gamma delta T cells engineered to be more potent and long-lasting against cancer

UCLA scientists have developed a new method to engineer more powerful immune cells that can potentially be used for "off-the-shelf" cell therapy to treat challenging cancers."Off-the-sh
World medicine November 15,2023
Study compiles the most comprehensive list of genetic variants associated with prostate cancer risk

Study compiles the most comprehensive list of genetic variants associated with prostate cancer risk

A globe-spanning scientific team has compiled the most comprehensive list of genetic variants associated with prostate cancer risk -; 451 in all -; through a whole-genome analysis that ranks as the la
World medicine November 15,2023
Study compiles the most comprehensive list of genetic variants associated with prostate cancer risk

Study compiles the most comprehensive list of genetic variants associated with prostate cancer risk

A globe-spanning scientific team has compiled the most comprehensive list of genetic variants associated with prostate cancer risk -; 451 in all -; through a whole-genome analysis that ranks as the la
World medicine November 15,2023
MD Anderson Cancer launches Institute for Data Science in to transform cancer care and research

MD Anderson Cancer launches Institute for Data Science in to transform cancer care and research

The University of Texas MD Anderson Cancer Center today announced the launch of its Institute for Data Science in Oncology (IDSO), which integrates the most advanced computational and data science app
World medicine November 15,2023
MD Anderson Cancer launches Institute for Data Science in to transform cancer care and research

MD Anderson Cancer launches Institute for Data Science in to transform cancer care and research

The University of Texas MD Anderson Cancer Center today announced the launch of its Institute for Data Science in Oncology (IDSO), which integrates the most advanced computational and data science app
World medicine November 15,2023
FORTE accrues first 1000 participants for highly anticipated colorectal cancer prevention trial

FORTE accrues first 1000 participants for highly anticipated colorectal cancer prevention trial

FORTE (NRG-CC005) is a highly anticipated colorectal cancer prevention trial led by NRG Oncology examining surveillance colonoscopy intervals in participants who have non-advanced polyps. Expected to
World medicine November 15,2023
FORTE accrues first 1000 participants for highly anticipated colorectal cancer prevention trial

FORTE accrues first 1000 participants for highly anticipated colorectal cancer prevention trial

FORTE (NRG-CC005) is a highly anticipated colorectal cancer prevention trial led by NRG Oncology examining surveillance colonoscopy intervals in participants who have non-advanced polyps. Expected to
World medicine November 15,2023
Preclinical research points to a promising new treatment option for pancreatic cancer patients

Preclinical research points to a promising new treatment option for pancreatic cancer patients

Preclinical research published in theJournal for ImmunoTherapy of Cancerpoints to a promising new treatment optionfor people with pancreatic cancer. Researchers from VCU Massey Compr
World medicine November 15,2023
Preclinical research points to a promising new treatment option for pancreatic cancer patients

Preclinical research points to a promising new treatment option for pancreatic cancer patients

Preclinical research published in theJournal for ImmunoTherapy of Cancerpoints to a promising new treatment optionfor people with pancreatic cancer. Researchers from VCU Massey Compr
World medicine November 15,2023
Novel microfluidic cell separation technology for early cancer detection

Novel microfluidic cell separation technology for early cancer detection

Early detection allows for timely intervention in many diseases before they progress to a severe stage, often at a lower treatment cost. This is particularly crucial in the case of cancer, as the stag
World medicine November 15,2023
Novel microfluidic cell separation technology for early cancer detection

Novel microfluidic cell separation technology for early cancer detection

Early detection allows for timely intervention in many diseases before they progress to a severe stage, often at a lower treatment cost. This is particularly crucial in the case of cancer, as the stag
World medicine November 15,2023
Can vitamins really fight cancer? New study uncovers surprising links between micronutrients and cancer risk

Can vitamins really fight cancer? New study uncovers surprising links between micronutrients and cancer risk

In a recent study published in the journalBMC Medicine,researchers evaluate the associations between micronutrients and cancer outcomes.Study:An atlas of associations between 14 micr
World medicine November 15,2023
Can vitamins really fight cancer? New study uncovers surprising links between micronutrients and cancer risk

Can vitamins really fight cancer? New study uncovers surprising links between micronutrients and cancer risk

In a recent study published in the journalBMC Medicine,researchers evaluate the associations between micronutrients and cancer outcomes.Study:An atlas of associations between 14 micr
World medicine November 15,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com